BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10083069)

  • 1. Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation.
    Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock E; Lynch J; Cooper J; Patterson GA; Mohanakumar T
    Transplant Proc; 1999; 31(1-2):185-6. PubMed ID: 10083069
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to human leukocyte antigens in lung transplantation.
    Hachem RR
    Clin Transpl; 2011; ():327-32. PubMed ID: 22755426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.
    Reznik SI; Jaramillo A; Zhang L; Patterson GA; Cooper JD; Mohanakumar T
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):39-45. PubMed ID: 10612759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
    Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1155-61. PubMed ID: 10232567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    Reznik SI; Jaramillo A; SivaSai KS; Womer KL; Sayegh MH; Trulock EP; Patterson GA; Mohanakumar T
    Am J Transplant; 2001 Sep; 1(3):228-35. PubMed ID: 12102256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.
    Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG
    J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
    Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
    J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
    Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.
    Sundaresan S; Mohanakumar T; Smith MA; Trulock EP; Lynch J; Phelan D; Cooper JD; Patterson GA
    Transplantation; 1998 Mar; 65(5):648-53. PubMed ID: 9521198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome.
    Jaramillo A; Naziruddin B; Zhang L; Reznik SI; Smith MA; Aloush AA; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2001 Apr; 71(7):966-76. PubMed ID: 11349733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
    Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation.
    Hayes D; Black SM; Tobias JD; Kopp BT; Kirkby SE; Mansour HM; Whitson BA
    J Heart Lung Transplant; 2016 Feb; 35(2):186-94. PubMed ID: 26496787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
    Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
    Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung transplantation: opportunities for research and clinical advancement.
    Magro CM; Pope-Harman AL; Abbas AE; Ross P
    Am J Respir Crit Care Med; 2006 Feb; 173(4):466-7; author reply 467. PubMed ID: 16467179
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL; McCurry KR; Zeevi A
    Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
    Appel JZ; Hartwig MG; Davis RD; Reinsmoen NL
    Hum Immunol; 2005 Apr; 66(4):378-86. PubMed ID: 15866701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
    Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
    Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On interleukin-8, neutrophil activation, and bronchiolitis obliterans syndrome in lung transplantation.
    Riise GC
    Transplantation; 2000 Jul; 70(2):265-6. PubMed ID: 10933146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.